463 related articles for article (PubMed ID: 34021586)
1. NLRP7: From inflammasome regulation to human disease.
Carriere J; Dorfleutner A; Stehlik C
Immunology; 2021 Aug; 163(4):363-376. PubMed ID: 34021586
[TBL] [Abstract][Full Text] [Related]
2. ATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptides.
Radian AD; Khare S; Chu LH; Dorfleutner A; Stehlik C
Mol Immunol; 2015 Oct; 67(2 Pt B):294-302. PubMed ID: 26143398
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications.
Fang X; Wang Y; Zhang Y; Li Y; Kwak-Kim J; Wu L
Front Immunol; 2020; 11():555826. PubMed ID: 33584639
[TBL] [Abstract][Full Text] [Related]
4. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.
Khare S; Dorfleutner A; Bryan NB; Yun C; Radian AD; de Almeida L; Rojanasakul Y; Stehlik C
Immunity; 2012 Mar; 36(3):464-76. PubMed ID: 22361007
[TBL] [Abstract][Full Text] [Related]
5. Human Amnion Epithelial Cells (AECs) Respond to the FSL-1 Lipopeptide by Engaging the NLRP7 Inflammasome.
Lavergne M; Belville C; Choltus H; Gross C; Minet-Quinard R; Gallot D; Sapin V; Blanchon L
Front Immunol; 2020; 11():1645. PubMed ID: 32849565
[No Abstract] [Full Text] [Related]
6. Three-dimensional structure of the NLRP7 pyrin domain: insight into pyrin-pyrin-mediated effector domain signaling in innate immunity.
Pinheiro AS; Proell M; Eibl C; Page R; Schwarzenbacher R; Peti W
J Biol Chem; 2010 Aug; 285(35):27402-27410. PubMed ID: 20547486
[TBL] [Abstract][Full Text] [Related]
7. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
8. NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease.
Radian AD; de Almeida L; Dorfleutner A; Stehlik C
Microbes Infect; 2013; 15(8-9):630-9. PubMed ID: 23618810
[TBL] [Abstract][Full Text] [Related]
9. Advances in Understanding Activation and Function of the NLRC4 Inflammasome.
Sundaram B; Kanneganti TD
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494299
[TBL] [Abstract][Full Text] [Related]
10. NLRP inflammasomes in health and disease.
Xu Z; Kombe Kombe AJ; Deng S; Zhang H; Wu S; Ruan J; Zhou Y; Jin T
Mol Biomed; 2024 Apr; 5(1):14. PubMed ID: 38644450
[TBL] [Abstract][Full Text] [Related]
11. The CARD plays a critical role in ASC foci formation and inflammasome signalling.
Proell M; Gerlic M; Mace PD; Reed JC; Riedl SJ
Biochem J; 2013 Feb; 449(3):613-21. PubMed ID: 23110696
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of NOD-like receptors and regulation of NLRP3 inflammasome activation in Toxoplasma gondii-infected human small intestinal epithelial cells.
Chu JQ; Gao FF; Wu W; Li C; Pan Z; Sun J; Wang H; Huang C; Lee SH; Quan JH; Lee YH
Parasit Vectors; 2021 Mar; 14(1):153. PubMed ID: 33712075
[TBL] [Abstract][Full Text] [Related]
13. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms governing inflammasome activation, assembly and pyroptosis induction.
Kesavardhana S; Kanneganti TD
Int Immunol; 2017 May; 29(5):201-210. PubMed ID: 28531279
[TBL] [Abstract][Full Text] [Related]
15. The role of the NLRP3 inflammasome in regulation of antiviral responses to influenza A virus infection.
Sarvestani ST; McAuley JL
Antiviral Res; 2017 Dec; 148():32-42. PubMed ID: 29097227
[TBL] [Abstract][Full Text] [Related]
16. Enigmatic inflammasomes.
Triantafilou K
Immunology; 2021 Mar; 162(3):249-251. PubMed ID: 33590488
[TBL] [Abstract][Full Text] [Related]
17. Inflammasomes: guardians of cytosolic sanctity.
Lamkanfi M; Dixit VM
Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
[TBL] [Abstract][Full Text] [Related]
18. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
[TBL] [Abstract][Full Text] [Related]
19. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins.
MacDonald JA; Wijekoon CP; Liao KC; Muruve DA
IUBMB Life; 2013 Oct; 65(10):851-62. PubMed ID: 24078393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]